Named as a key player in 66 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Healthcare In Vitro Diagnostic | Healthcare Services | $83.5 Bn | 3.8% |
| Antimicrobial Susceptibility Testing | Healthcare Services | – | – |
Named as key players in the same markets as Sysmex Corporation (number of shared markets).
Accelerate Diagnostics, Inc.1 shared market
Alifax S.r.l.1 shared market
BD1 shared market
Becton, Dickinson and Company (BD)1 shared market
Bio-Rad Laboratories, Inc.1 shared market